JP2015535523A5 - - Google Patents

Download PDF

Info

Publication number
JP2015535523A5
JP2015535523A5 JP2015540978A JP2015540978A JP2015535523A5 JP 2015535523 A5 JP2015535523 A5 JP 2015535523A5 JP 2015540978 A JP2015540978 A JP 2015540978A JP 2015540978 A JP2015540978 A JP 2015540978A JP 2015535523 A5 JP2015535523 A5 JP 2015535523A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015540978A
Other languages
Japanese (ja)
Other versions
JP2015535523A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2013/050863 external-priority patent/WO2014071531A1/en
Publication of JP2015535523A publication Critical patent/JP2015535523A/ja
Publication of JP2015535523A5 publication Critical patent/JP2015535523A5/ja
Pending legal-status Critical Current

Links

JP2015540978A 2012-11-12 2013-11-12 アプロチニン由来ポリペプチド−抗体コンジュゲート Pending JP2015535523A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261725365P 2012-11-12 2012-11-12
US61/725,365 2012-11-12
PCT/CA2013/050863 WO2014071531A1 (en) 2012-11-12 2013-11-12 Aprotinin-derived polypeptide-antibody conjugates

Publications (2)

Publication Number Publication Date
JP2015535523A JP2015535523A (ja) 2015-12-14
JP2015535523A5 true JP2015535523A5 (enExample) 2016-06-30

Family

ID=50683885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015540978A Pending JP2015535523A (ja) 2012-11-12 2013-11-12 アプロチニン由来ポリペプチド−抗体コンジュゲート

Country Status (13)

Country Link
US (1) US20160213760A1 (enExample)
EP (1) EP2917244B1 (enExample)
JP (1) JP2015535523A (enExample)
CN (1) CN105026432A (enExample)
AU (1) AU2013344253A1 (enExample)
BR (1) BR112015010668A2 (enExample)
CA (1) CA2891190C (enExample)
DK (1) DK2917244T3 (enExample)
ES (1) ES2855169T3 (enExample)
IN (1) IN2015DN04294A (enExample)
MX (1) MX377795B (enExample)
RU (1) RU2015121818A (enExample)
WO (1) WO2014071531A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2424242T3 (es) 2005-07-15 2013-09-30 Angiochem Inc. Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
CA2740316A1 (en) 2008-10-15 2010-04-22 Angiochem Inc. Conjugates of glp-1 agonists and uses thereof
MX2011005963A (es) 2008-12-05 2011-09-01 Angiochem Inc Conjugados de neurotensina o analogos de neurotensina y sus usos.
CN104781276A (zh) 2012-08-14 2015-07-15 安吉奥开米公司 肽-树枝状聚合物结合物及其用途
WO2016073833A1 (en) * 2014-11-06 2016-05-12 Cell Idx, Inc. High-affinity immunopolymers
CA2976005A1 (en) 2015-02-06 2016-08-11 Cell Idx, Inc. Antigen-coupled immunoreagents
DK3307326T3 (da) 2015-06-15 2020-10-19 Angiochem Inc Fremgangsmåder til behandling af leptomeningeal karcinomatose
US12358998B2 (en) 2018-06-29 2025-07-15 City Of Hope Anti-CD6 antibody-growth factor complex for treating autoimmune diseases
GB201906917D0 (en) * 2019-05-16 2019-07-03 Intract Pharma Ltd Novel compositions
EP3986439A4 (en) * 2019-06-21 2023-10-04 University of Kansas COMPOSITIONS AND METHODS USEFUL IN THE TREATMENT OF BRAIN DISEASES
EP4142737A4 (en) * 2020-04-27 2024-06-05 Aruna Bio, Inc. BINDING AGENTS AND USES THEREOF FOR CENTRAL NERVOUS SYSTEM DEPRESSION
WO2022099062A2 (en) * 2020-11-09 2022-05-12 The General Hospital Corporation Antibodies and single-chain variable region proteins recognizing click products

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
ES2424242T3 (es) * 2005-07-15 2013-09-30 Angiochem Inc. Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
CN101815724B (zh) * 2007-05-29 2015-02-25 安吉奥开米公司 用于将轭合至其的试剂递送至组织的抑肽酶样多肽
BRPI1015295A2 (pt) * 2009-04-20 2016-05-31 Angiochem Inc traamento de câncer de ovário usando um agente anticâncer conjugado a um análogo angiopep-2.
PL2719708T3 (pl) * 2009-11-13 2018-04-30 Daiichi Sankyo Europe Gmbh Materiał i sposoby leczenia lub zapobiegania chorobom związanym z HER-3
US20130280281A1 (en) * 2010-07-02 2013-10-24 Jean-Paul Castaigne Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
EP2588490B1 (en) * 2010-07-02 2017-02-22 Angiochem Inc. Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof

Similar Documents

Publication Publication Date Title
AP2016009275A0 (enExample)
BR112015007533A2 (enExample)
BR102016010778A2 (enExample)
BR112014017733A2 (enExample)
BR112014018502A2 (enExample)
BR112014017739A2 (enExample)
BR112014019326A2 (enExample)
BR112014018480A2 (enExample)
BR112014018516A2 (enExample)
BR112014020341A2 (enExample)
BR112014017855A2 (enExample)
BR112014017765A2 (enExample)
BR112014017669A2 (enExample)
BR112014021878A2 (enExample)
BR112014018468A2 (enExample)
BR112014017901A2 (enExample)
BR112014019204A2 (enExample)
BR112014018207A2 (enExample)
BR112015015948A2 (enExample)
BR112014017722A2 (enExample)
BR112014017653A2 (enExample)
JP2015535523A5 (enExample)
BR112014018578A2 (enExample)
BR112014018483A2 (enExample)
BR112014017794A2 (enExample)